List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 35 studies with search of: "Viremia"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Yellow Fever Virus Vaccine and Immune Globulin Study
Conditions: Viremia;   Immune Response to Yellow Fever Virus Vaccination
Intervention: Biological: YF-VAX and Gama STAN S/D
2 Recruiting Viral Load in Blood and Lymph Tissues of HIV-Infected Individuals
Conditions: HIV Infection;   Viremia
Intervention:
3 Active, not recruiting Induction Related BK Viremia in Renal Transplant Patients
Conditions: Polyoma Virus;   Organ Transplants
Intervention:
4 Recruiting Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection
Conditions: HIV Infections;   Hepatitis B
Interventions: Drug: Entecavir with continued standard of care antiretroviral therapy;   Drug: continued standard of care with tenofovir in addition to emtricitabine or lamivudine
5 Active, not recruiting BK Viremia After Renal Transplantation
Conditions: Terminal Renal Failure;   BK Virus Infection
Intervention: Drug: leflunomide
6 Completed Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV Infection
Conditions: HIV Infections;   Stomatitis, Aphthous
Intervention: Drug: Thalidomide
7 Not yet recruiting Pilot Study to Evaluate HIV Viremia and Persistence in Acutely HIV-Infected Antiretroviral Naïve Patients Treated With Darunavir/Ritonavir and Etravirine
Conditions: Acute HIV Infection;   HIV Infections
Intervention: Drug: Darunavir/Ritonavir and Etravirine
8 Completed A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria
Conditions: Cytomegalovirus Infections;   HIV Infections
Intervention: Drug: Sevirumab
9 Recruiting Pilot Study of the Impact of Adding Raltegravir (MK-0518) to Antiretroviral Therapy in Patients With Undetectable Plasma Virus
Condition: HIV Infections
Intervention: Drug: Raltegravir (MK-0518)
10 Completed Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV
Conditions: Cytomegalovirus Infections;   HIV Infections
Intervention: Drug: Valganciclovir
11 Completed BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r)
Condition: HIV Infections
Intervention: Drug: Increased dose of Kaletra
12 Active, not recruiting Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil
Condition: Chronic Hepatitis B
Interventions: Drug: tenofovir DF;   Drug: emtricitabine /tenofovir DF
13 Completed Alternative Dosing Strategy for Anti-HIV Drugs
Condition: HIV Infections
Intervention: Behavioral: Concentration-controlled therapy
14 Completed VICTOR Study - A Study of Valcyte (Valganciclovir po) Compared to Ganciclovir iv in Patients With Cytomegalovirus (CMV) Disease Who Are Solid Organ Transplant Recipients
Condition: Cytomegalovirus Infections
Interventions: Drug: valganciclovir [Valcyte];   Drug: Ganciclovir
15 Active, not recruiting Effects of Therapeutic HIV Vaccination on Control of HIV After Discontinuation of Anti-HIV Drugs
Condition: HIV Infections
Intervention:
16 Completed Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With Hyperlipidemia
Conditions: Hyperlipidemia;   HIV Infections
Intervention: Drug: Atazanavir
17 Completed Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients
Condition: Hepatitis B
Intervention: Drug: Entecavir
18 Completed "OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleosides From Triple-Drug Therapy in HIV Subjects
Condition: HIV Infection
Intervention: Drug: Stopping nucleosides and continuing lopinavir/ritonavir monotherapy
19 Not yet recruiting Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men
Condition: HIV Infections
Interventions: Biological: DNA plasmid vaccine;   Biological: HIV-1 recombinant adenovirus vaccine;   Biological: DNA plasmid vaccine placebo;   Biological: HIV-1 recombinant adenovirus vaccine placebo
20 Active, not recruiting Efficacy of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
Condition: HIV Infections
Interventions: Drug: Raltegravir (MK-0518);   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-35)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services